{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T08:21:21Z","timestamp":1782375681170,"version":"3.54.5"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2020,9,12]],"date-time":"2020-09-12T00:00:00Z","timestamp":1599868800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,9,12]],"date-time":"2020-09-12T00:00:00Z","timestamp":1599868800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Gastrointest Canc"],"published-print":{"date-parts":[[2021,9]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Purpose<\/jats:title>\n                <jats:p>Describe sociodemographic and clinical characteristics of patients with hepatocellular carcinoma (HCC) and establish their history in the Brazilian public health system.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Retrospective observational study was conducted using the database from the Department of Informatics of the Unified Health System (DataSUS). Patients with at least one claim of HCC between July\/2011 and June\/2016 were included. A record linkage methodology was performed to obtain longitudinal data across different databases. Demographic and clinical data were evaluated, including the time elapsed between diagnosis of HCC risk-factors and the cancer development. Data was analyzed using descriptive statistics.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>A total of 28,822 HCC cases were identified between July\/2011 and June\/2016. Mean age was 59.7 years (SD = 14.7), and most patients were men (55.9%). The highest relative number of HCC cases was detected in the south of Brazil (&gt; 20 cases\/100,000 inhabitants). About 86.5% of the patients had diagnosis of HCC without previous liver diseases. Only 8% had diagnosis of chronic viral hepatitis and 3.5% cirrhosis. About 76% were diagnosed at an advanced stage, and only 11% of the patients had early stage HCC. Approximately 58% of patients with previous underlying liver diseases were diagnosed at early stages, compared with only 24% of patients without prior record of underlying diseases.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>The diagnosis of HCC in the Brazilian public health is usually made in patients with no previous diagnosis of liver disease and in advanced stages, when no curative treatment is available and survival rates are low. Public health policies are key for the screening and monitoring liver disease and, consequently, HCC.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s12029-020-00508-7","type":"journal-article","created":{"date-parts":[[2020,9,12]],"date-time":"2020-09-12T03:47:28Z","timestamp":1599882448000},"page":"952-958","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Epidemiological and Clinical Patterns of Newly Diagnosed Hepatocellular Carcinoma in Brazil: the Need for Liver Disease Screening Programs Based on Real-World Data"],"prefix":"10.1007","volume":"52","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3426-2167","authenticated-orcid":false,"given":"Gustavo dos Santos","family":"Fernandes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Campos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andre","family":"Ballalai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodrigo","family":"Palhares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario R. A.","family":"da Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel M. F.","family":"Palhares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ben-Hur F.","family":"Neto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio M. do R.","family":"Barros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto de A.","family":"Gil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aline","family":"Chagas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flair Jos\u00e9","family":"Carrilho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,9,12]]},"reference":[{"issue":"1","key":"508_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.soc.2014.09.001","volume":"24","author":"KJ Lafaro","year":"2015","unstructured":"Lafaro KJ, Demirjian AN, Pawlik TM. Epidemiology of hepatocellular carcinoma. Surg Oncol Clin N Am. 2015;24(1):1\u201317.","journal-title":"Surg Oncol Clin N Am"},{"key":"508_CR2","unstructured":"International Agency for Research on Cancer. The Global Cancer Observatory: cancer fact sheets: liver and intrahepatic bile ducts (C22): Liver Sheet. Source: Globocan; 2018. https:\/\/gco.iarc.fr\/today\/data\/factsheets\/cancers\/11-Liver-fact-sheet.pdf. Accessed 23 May 2020"},{"issue":"2","key":"508_CR3","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.suronc.2016.03.002","volume":"25","author":"MS Grandhi","year":"2016","unstructured":"Grandhi MS, Kim AK, Ronnekleiv-Kelly SM, et al. Hepatocellular carcinoma: From diagnosis to treatment. Surg Oncol. 2016;25(2):74\u201385.","journal-title":"Surg Oncol"},{"issue":"5 Suppl 1","key":"508_CR4","doi-asserted-by":"publisher","first-page":"S35","DOI":"10.1053\/j.gastro.2004.09.014","volume":"127","author":"G Fattovich","year":"2004","unstructured":"Fattovich G, Stroffolini T, Zagni I, et al. Hepatocellular carcinoma in cirrhosis: incidence and risk factors. Gastroenterology. 2004;127(5 Suppl 1):S35\u201350.","journal-title":"Gastroenterology."},{"issue":"5 Suppl 1","key":"508_CR5","doi-asserted-by":"publisher","first-page":"S56","DOI":"10.1053\/j.gastro.2004.09.016","volume":"127","author":"C Brechot","year":"2004","unstructured":"Brechot C. Pathogenesis of hepatitis B virus-related hepatocellular carcinoma: old and new paradigms. Gastroenterology. 2004;127(5 Suppl 1):S56\u201361.","journal-title":"Gastroenterology."},{"issue":"4","key":"508_CR6","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1586\/egh.09.35","volume":"3","author":"MI Shariff","year":"2009","unstructured":"Shariff MI, Cox IJ, Gomaa AI, et al. Hepatocellular carcinoma: current trends in worldwide epidemiology, risk factors, diagnosis and therapeutics. Expert Rev Gastroenterol Hepatol. 2009;3(4):353\u201367.","journal-title":"Expert Rev Gastroenterol Hepatol"},{"issue":"37","key":"508_CR7","doi-asserted-by":"publisher","first-page":"4224","DOI":"10.3748\/wjg.v24.i37.4224","volume":"24","author":"F Pinero","year":"2018","unstructured":"Pinero F, Poniachik J, Ridruejo E, et al. Hepatocellular carcinoma in Latin America: diagnosis and treatment challenges. World J Gastroenterol. 2018;24(37):4224\u20139.","journal-title":"World J Gastroenterol"},{"key":"508_CR8","doi-asserted-by":"crossref","unstructured":"Carrilho FJ, Paranagu\u00e1-Vezozzo DC, Chagas AL, et al (2019) Epidemiology of liver cancer in Latin America: current and future trends. Semin Liv Dis","DOI":"10.1055\/s-0039-3399561"},{"key":"508_CR9","doi-asserted-by":"publisher","first-page":"445","DOI":"10.3851\/IMP2602","volume":"18","author":"L Kikuchi","year":"2013","unstructured":"Kikuchi L, Chagas AL, Alencar RSSM, et al. Clinical and epidemiological aspects of hepatocellular carcinoma in Brazil. Antivir Ther. 2013;18:445\u20139.","journal-title":"Antivir Ther"},{"issue":"2","key":"508_CR10","doi-asserted-by":"publisher","first-page":"87","DOI":"10.3322\/caac.21262","volume":"65","author":"LA Torre","year":"2015","unstructured":"Torre LA, Bray F, Siegel RL, et al. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65(2):87\u2013108.","journal-title":"CA Cancer J Clin"},{"issue":"5","key":"508_CR11","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1080\/17474124.2018.1453806","volume":"12","author":"G Zhang","year":"2018","unstructured":"Zhang G, Li R, Deng Y, Zhao L. Conditional survival of patients with hepatocellular carcinoma: results from the Surveillance, Epidemiology, and End Results registry. Expert Rev Gastroenterol Hepatol. 2018 May;12(5):515\u201323.","journal-title":"Expert Rev Gastroenterol Hepatol"},{"issue":"41","key":"508_CR12","doi-asserted-by":"publisher","first-page":"9069","DOI":"10.3748\/wjg.v22.i41.9069","volume":"22","author":"ZS Niu","year":"2016","unstructured":"Niu ZS, Niu XJ, Wang WH. Genetic alterations in hepatocellular carcinoma: An update. World J Gastroenterol. 2016;22(41):9069\u201395.","journal-title":"World J Gastroenterol"},{"issue":"9","key":"508_CR13","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1200\/JCO.2008.20.7753","volume":"27","author":"SF Altekruse","year":"2009","unstructured":"Altekruse SF, McGlynn KA, Reichman ME. Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005. J Clin Oncol. 2009;27(9):1485\u201391.","journal-title":"J Clin Oncol"},{"issue":"2","key":"508_CR14","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1053\/j.semdp.2016.12.011","volume":"34","author":"J Hartke","year":"2017","unstructured":"Hartke J, Johnson M, Ghabril M. The diagnosis and treatment of hepatocellular carcinoma. Semin Diagn Pathol. 2017;34(2):153\u20139.","journal-title":"Semin Diagn Pathol"},{"issue":"4","key":"508_CR15","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/S1665-2681(19)30845-2","volume":"13","author":"DC Paranagua-Vezozzo","year":"2014","unstructured":"Paranagua-Vezozzo DC, Ono SK, Alvarado-Mora MV, et al. Epidemiology of HCC in Brazil: incidence and risk factors in a ten-year cohort. Ann Hepatol. 2014;13(4):386\u201393.","journal-title":"Ann Hepatol"},{"key":"508_CR16","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1590\/S0004-28032013000200015","volume":"50","author":"FMF Os\u00f3rio","year":"2013","unstructured":"Os\u00f3rio FMF, Lauar GM, Lima AS, et al. Epidemiological aspects of hepatocellular carcinoma in a referral center of Minas Gerais, Brazil. Arq Gastroenterol. 2013;50:97\u2013100.","journal-title":"Arq Gastroenterol"},{"issue":"2","key":"508_CR17","doi-asserted-by":"publisher","first-page":"255","DOI":"10.5604\/16652681.1231586","volume":"16","author":"SR Almeida-Carvalho","year":"2017","unstructured":"Almeida-Carvalho SR, Gomes-Ferraz ML, Loureiro-Matos CA, et al. Practical considerations of real life of hepatocellular carcinoma in a tertiary center of Brazil. Ann Hepatol. 2017;16(2):255\u201362.","journal-title":"Ann Hepatol"},{"issue":"3","key":"508_CR18","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1590\/S0036-46651997000300008","volume":"39","author":"CS Goncalves","year":"1997","unstructured":"Goncalves CS, Pereira FE, Gayotto LC. Hepatocellular carcinoma in Brazil: report of a national survey (Florianopolis, SC, 1995). Rev Inst Med Trop Sao Paulo. 1997;39(3):165\u201370.","journal-title":"Rev Inst Med Trop Sao Paulo"},{"key":"508_CR19","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1590\/S0104-42302007000600013","volume":"53","author":"A Castelo","year":"2007","unstructured":"Castelo A, Pess\u00f4a MG, Barreto TCBB, et al. Estimativas de custo da hepatite cr\u00f4nica B no sistema \u00fanico de sa\u00fade Brasileiro em 2005. Rev Assoc M\u00e9d Bras. 2007;53:486\u201391.","journal-title":"Rev Assoc M\u00e9d Bras"},{"key":"508_CR20","doi-asserted-by":"publisher","first-page":"361","DOI":"10.6061\/clinics\/2016(07)01","volume":"71","author":"IV Signorelli","year":"2016","unstructured":"Signorelli IV, Gon\u00e7alves PL, Gon\u00e7alves LL, et al. Socioeconomic disparities in access to a hepatocellular carcinoma screening program in Brazil. Clinics. 2016;71:361\u20134.","journal-title":"Clinics."},{"issue":"8","key":"508_CR21","doi-asserted-by":"publisher","first-page":"454","DOI":"10.6061\/clinics\/2017(08)01","volume":"72","author":"L Kikuchi","year":"2017","unstructured":"Kikuchi L, Chagas AL, Alencar R, et al. Adherence to BCLC recommendations for the treatment of hepatocellular carcinoma: impact on survival according to stage. Clinics (Sao Paulo). 2017;72(8):454\u201360.","journal-title":"Clinics (Sao Paulo)"},{"issue":"5","key":"508_CR22","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1159\/000490378","volume":"36","author":"L Longo","year":"2018","unstructured":"Longo L, de Freitas LBR, Santos D, et al. Sorafenib for advanced hepatocellular carcinoma: a real-life experience. Dig Dis. 2018;36(5):377\u201384.","journal-title":"Dig Dis"},{"issue":"4","key":"508_CR23","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1016\/j.jhep.2011.12.001","volume":"56","author":"European Association for","year":"2012","unstructured":"European Association for. The Study of The Liver, European Organization for Research and Treatment of Cancer. EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol. 2012;56(4):908\u201343.","journal-title":"J Hepatol"},{"key":"508_CR24","doi-asserted-by":"publisher","first-page":"2297","DOI":"10.1590\/S1413-81232010000500005","volume":"15","author":"EV Mendes","year":"2010","unstructured":"Mendes EV. As redes de aten\u00e7\u00e3o \u00e0 sa\u00fade. Ci\u00eanc Sa\u00fade Coletiva. 2010;15:2297\u2013305.","journal-title":"Ci\u00eanc Sa\u00fade Coletiva"}],"updated-by":[{"DOI":"10.1007\/s12029-020-00539-0","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2020,10,26]],"date-time":"2020-10-26T00:00:00Z","timestamp":1603670400000}}],"container-title":["Journal of Gastrointestinal Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12029-020-00508-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12029-020-00508-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12029-020-00508-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,12]],"date-time":"2021-09-12T00:02:50Z","timestamp":1631404970000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12029-020-00508-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,12]]},"references-count":24,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["508"],"URL":"https:\/\/doi.org\/10.1007\/s12029-020-00508-7","relation":{"correction":[{"id-type":"doi","id":"10.1007\/s12029-020-00539-0","asserted-by":"object"}]},"ISSN":["1941-6628","1941-6636"],"issn-type":[{"value":"1941-6628","type":"print"},{"value":"1941-6636","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,12]]},"assertion":[{"value":"12 September 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 October 2020","order":2,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":3,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":4,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s12029-020-00539-0","URL":"https:\/\/doi.org\/10.1007\/s12029-020-00539-0","order":5,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"No (public data used)","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"Not applicable (public data used)","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"All authors reviewed and consent the publication of this manuscript.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"Not applicable (public data used)","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed Consent"}},{"value":"This research used public database of Brazilian public health system.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights"}}]}}